Pharmaceuticals Insider Trading
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
Activity
About industry performance (blue line)
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.
Recent Transactions
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2016 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 131,040 | $56.11 | $7,352,942.69 | -20.1% | |
| Apr 13, 2016 | PRGO Perrigo Co Plc | Brown Judy L | Executive VP &CFO | Sell | 2,776 | $126.22 | $350,386.72 | -10.0% | |
| Apr 12, 2016 | SBFM Sunshine Biopharma Inc. | Slilaty Steve N. | Chief Executive Officer | Buy | 253,082 | $0.20 | $50,009.00 | +0.8% | |
| Apr 12, 2016 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Buy | 300,000 | $10.00 | $3,000,000.00 | +14.9% | |
| Apr 11, 2016 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 30,762 | $16.49 | $507,228.47 | -34.9% | |
| Apr 8, 2016 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $74.29 | $14,857,800.00 | -0.2% | |
| Apr 6, 2016 | EBS Emergent Biosolutions Inc. | Kramer Robert | EVP, Corporate Services Divisi | Sell | 21,786 | $38.90 | $847,475.40 | -5.8% | |
| Apr 6, 2016 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 50,000 | $39.00 | $1,950,000.00 | -1.4% | |
| Apr 4, 2016 | EBS Emergent Biosolutions Inc. | Kramer Robert | EVP, Corporate Services Divisi | Sell | 21,788 | $36.90 | $803,977.20 | -5.5% | |
| Apr 4, 2016 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Business Officer | Sell | 1,401 | $9.41 | $13,183.41 | -1.8% | |
| Apr 4, 2016 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, General Counsel, Sec. | Sell | 1,556 | $9.41 | $14,641.96 | -1.8% | |
| Apr 1, 2016 | EBS Emergent Biosolutions Inc. | Kramer Robert | EVP, Corporate Services Divisi | Sell | 43,572 | $35.56 | $1,549,594.65 | -7.3% | |
| Apr 1, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | President And CEO | Sell | 30,765 | $40.63 | $1,249,981.95 | -2.2% | |
| Apr 1, 2016 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 8,000 | $27.02 | $216,151.88 | -100% | |
| Mar 22, 2016 | AVDL Avadel Pharmaceuticals Plc | Thompson Phillandas T. | See Remarks | Buy | 10,000 | $11.10 | $111,030.00 | +100.0% | |
| Mar 18, 2016 | AVDL Avadel Pharmaceuticals Plc | Hatten Sandra L | Sr. VP, Quality &Reg Affairs | Buy | 3,000 | $11.01 | $33,030.00 | New | |
| Mar 18, 2016 | PRGO Perrigo Co Plc | Jandernoa Michael J | Director | Sell | 761 | $128.29 | $97,628.69 | -8.8% | |
| Mar 18, 2016 | AVDL Avadel Pharmaceuticals Plc | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $11.04 | $55,220.00 | +4.0% | |
| Mar 18, 2016 | ELTP Elite Pharmaceuticals Inc /nv/ | Treppel Jerry | Former Chairman | Sell | 570,520 | $0.34 | $196,055.13 | -3.5% | |
| Mar 17, 2016 | CPIX Cumberland Pharmaceuticals Inc | Lawrence Thomas R | Director | Sell | 5,000 | $4.34 | $21,700.00 | -9.9% | |
| Mar 17, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 2,400 | $11.25 | $27,000.00 | -8.4% | |
| Mar 15, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Graves Michael | Director | Buy | 1,000 | $56.73 | $56,730.00 | New | |
| Mar 14, 2016 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 2,350 | $33.88 | $79,618.00 | -14.3% | |
| Mar 14, 2016 | AVDL Avadel Pharmaceuticals Plc | Anderson Michael S | Chief Executive Office | Buy | 10,000 | $9.74 | $97,350.00 | +8.8% | |
| Mar 14, 2016 | AVDL Avadel Pharmaceuticals Plc | Stapleton Craig R | Director | Buy | 100,000 | $10.39 | $1,039,400.00 | +26.1% |